01 1Fresenius Kabi AB Brunna
01 1PIPERACILLIN SODIUM/ TAZOBACTAM SODIUM (8:1) STERILE LYOPHILIZED
01 1Sweden
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-31
Pay. Date : 2013-12-17
DMF Number : 25545
Submission : 2011-11-29
Status : Active
Type : II
20
Fresenius Kabi Ipsum Srl, based in Sweden, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PIPERACILLIN SODIUM/ TAZOBACTAM SODIUM (8:1) STERILE LYOPHILIZED, with a corresponding US DMF Number 25545.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 31, 2014, and payment made on December 17, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
